Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective and Prospective Multicenter Study Evaluating the Impact of Treatment With Cytoreducing Agents on the Recurrence of Thrombosis in Thrombotic Patients With a Diagnosis of Myeloproliferative Neoplasia and Normal Blood Counts - a FIM Study

NCT04539678 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT04539678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04539678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective and Prospective Multicenter Study Evaluating the Impact of Treatment With Cytoreducing Agents on the Recurrence of Thrombosis in Thrombotic Patients With a Diagnosis of Myeloproliferative Neoplasia and Normal Blood Counts - a FIM Study
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
May 21, 2019
Completion date
December 31, 2023
Enrollment
253 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diagnosis of myeloproliferative neoplasia, impact of treatment with cytoreducing agent, thrombotic patients